Dr. Barry Dworkin

Breast cancer risk from hormone replacement needs perspective when compared to other contributing factors

Madely Health Headlines Commentary for November 18, 2010

Source:
Breast cancer risk of hormone therapy overblown, group says

Reference:

Misinformation. Misinterpretation. Missed opportunity

Related posts:

  1. Paxil interferes with tamoxifen's efficacy combating breast cancer/Sunday House Call returns to the airwaves
  2. Hormone replacement therapy revisited after review of data supports use for certain women
  3. Breast cancer screening for 40-49 year old women not supported by solid evidence: Politics will now supersede sound science and trash it
  4. Study follow up on hormone replacement therapy for women confirms benefit for menopausal symptoms but not for disease prevention